Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity:A Multicenter, Randomized, Double-Blind, Placebo-Controlled Superiority Trial

NCT07135141 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.

NCT NCT07135141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07135141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity:A Multicenter, Randomized, Double-Blind, Placebo-Controlled Superiority Trial
Lead sponsor
Beijing Friendship Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
September 30, 2029
Enrollment
256 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

severe obesity